# A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants

> **NCT05278676** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Dotinurad

## Key facts

- **NCT ID:** NCT05278676
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2022-12-13
- **Final completion:** 2022-12-13
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05278676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05278676, "A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05278676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*